Resultados de procura - David Voduc
- Mostrando 1 - 10 Resultados de 10
-
1
Tissue Microarrays in Clinical Oncology por David Voduc, Challayne Kenney, Torsten O. Nielsen
Publicado 2008Revisão -
2
-
3
-
4
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype por Maggie C.U. Cheang, David Voduc, Chris Bajdik, Samuel Leung, Steven McKinney, Stephen Chia, Charles M. Perou, Torsten O. Nielsen
Publicado 2008Artigo -
5
-
6
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer por Maggie C.U. Cheang, Stephen Chia, David Voduc, Dongxia Gao, Samuel Leung, Jacqueline Snider, Mark Watson, Sherri R. Davies, Philip S. Bernard, Joel S. Parker, Charles M. Perou, Matthew J. Ellis, Torsten O. Nielsen
Publicado 2009Artigo -
7
Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial por Maggie C.U. Cheang, K. David Voduc, Dongsheng Tu, Shan Jiang, Samuel Leung, Stephen Chia, Lois E. Shepherd, Mark N. Levine, Kathleen I. Pritchard, Sherri R. Davies, Inge J. Stijleman, Carole Davis, Mark Ebbert, Joel S. Parker, Matthew J. Ellis, Philip S. Bernard, Charles M. Perou, Torsten O. Nielsen
Publicado 2012Artigo -
8
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes por Joel S. Parker, Michael E. Mullins, Maggie C.U. Cheang, Samuel Leung, David Voduc, Tammi L. Vickery, Sherri R. Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu, John F. Quackenbush, Inge J. Stijleman, Juan Palazzo, J. S. Marron, Andrew B. Nobel, Elaine R. Mardis, Torsten O. Nielsen, Matthew J. Ellis, Charles M. Perou, Philip S. Bernard
Publicado 2023Artigo -
9
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression por Maggie C.U. Cheang, Miguel Martín, Torsten O. Nielsen, Aleix Prat, David Voduc, Álvaro Rodríguez-Lescure, Amparo Ruı́z, Stephen Chia, Lois E. Shepherd, Manuel Ruíz‐Borrego, Lourdes Calvo, Emilio Alba, Eva Carrasco, Rosalía Caballero, Dongsheng Tu, Kathleen I. Pritchard, Mark N. Levine, Vivien Bramwell, Joel S. Parker, Philip S. Bernard, Matthew J. Ellis, Charles M. Perou, Angelo Di Leo, Lisa A. Carey
Publicado 2015Artigo -
10
The prognostic effects of somatic mutations in ER-positive breast cancer por Obi L. Griffith, Nicholas C. Spies, Meenakshi Anurag, Malachi Griffith, Jingqin Luo, Dongsheng Tu, Belinda Yeo, Jason Kunisaki, Christopher A. Miller, Kilannin Krysiak, Jasreet Hundal, Benjamin J. Ainscough, Zachary L. Skidmore, Katie M. Campbell, Runjun D. Kumar, Catrina C. Fronick, Lisa Cook, Jacqueline Snider, Sherri R. Davies, Shyam M. Kavuri, Eric C. Chang, Vincent Magrini, David E. Larson, Robert S. Fulton, Shuzhen Liu, Samuel Leung, David Voduc, Ron Bose, Mitch Dowsett, Richard K. Wilson, Torsten O. Nielsen, Elaine R. Mardis, Matthew J. Ellis
Publicado 2018Artigo
Ferramentas de procura:
Materias Relacionadas
Cancer
Medicine
Oncology
Breast cancer
Internal medicine
Biology
Pathology
Tissue microarray
Estrogen receptor
Immunohistochemistry
Anthracycline
Cancer research
Basal (medicine)
Biochemistry
Bioinformatics
Biomarker
Chemotherapy
Computational biology
Confidence interval
Gene
Genetics
Insulin
Lymph node
Progesterone receptor
Proportional hazards model
Biomarker discovery
Clinical Oncology
Computer science
Cyclophosphamide
Cytokeratin